| All participants | Intervention group (Group A) (n=57) | Control group (Group B) (n=60) | p-value |
---|---|---|---|---|
Participants’ characteristics | ||||
 Age (years): mean (SD) | 42 (14) | 43 (15) | 41 (14) | 0.58 |
 Sex (n (%)) | ||||
  Male | 65 (55.6) | 33 (50.8) | 32 (49.2) |  |
  Female | 52 (44.4) | 24 (46.2) | 28 (53.8) | 0.62 |
 Medical history (n (%)) | ||||
  None | 85 (72.6) | 36 (42.3) | 49 (57.6) | 0.06 |
  Asthma | 8 (6.8) | 3 (37.5) | 5 (62.5) | 0.26 |
  Diabetes millitus | 14 (11.9) | 7 (50.0) | 7 (50.0) | 0.81 |
  Arterial hypertension | 8 (6.8) | 6 (75.0) | 2 (25.0) | 0.66 |
  Others | 7 (5.9) | 5 (71.4) | 2 (28.5) | 0.85 |
 Symptoms (n (%)) | ||||
  None | 77 (65.8) | 34 (44.2) | 43 (55.8) | 0.35 |
  Otorhinolaryngologic symptomsa | 15 (12.8) | 7 (46.7) | 8 (53.3) | 0.85 |
  Respiratory symptoms b | 7 (6.0) | 4 (57.1) | 3 (42.9) | 0.51 |
  Digestive disordersc | 3 (2.6) | 1 (33.3) | 2 (66.7) | 0.71 |
  General signsd | 15 (12.8) | 4 (26.7) | 11 (73.3) | 0.047 |
Baseline Ct values: mean (SD) | ||||
 All |  | 29.0 | 30.0 | 0.653 |
 Clinical form | ||||
  Symptomatic form | 27.7 (12.9) | 26.1 (14.2) | 29.6 (11.5) | 0.421 |
  Asymptomatic form | 30.37 (9.63) | 30.7 (9.2) | 30 (10.1) | 0.787 |
 Symptoms | ||||
  None | 30.5 (9.4) | 30.8 (9) | 30.2 (9.8) | 0.805 |
  Otorhinolaryngological symptomsa | 30 (9.3) | 26 (13.1) | 33.1 (3.5) | 0.166 |
  Respiratory symptomsb | 33.6 (2.88) | 32.5 (3.5) | 34.3 (2.8) | 0.565 |
  General signsd | 24.4 (16.3) | 24 (16.8) | 25.5 (17.2) | 0.884 |
 Medical history | ||||
  No | 30.3 (9.6) | 28.8 (11.2) | 31.3 (8.2) | 0.322 |
  Yes | 27.3 (13.3) | 28.3 (12.5) | 26 (14.7) | 0.639 |